Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany-the SUFEETUBE project.
Dysphagia
Gastrostomy tube
Malnutrition
Mucositis
PEG
Journal
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469
Informations de publication
Date de publication:
21 Feb 2024
21 Feb 2024
Historique:
received:
28
09
2023
accepted:
23
01
2024
medline:
21
2
2024
pubmed:
21
2
2024
entrez:
21
2
2024
Statut:
aheadofprint
Résumé
Data on enteral tube feeding in head and neck cancer (HNC) patients undergoing chemoradiotherapy vary considerably between German institutions. This survey aims to investigate the management of feeding tubes in an interdisciplinary context across Germany. Between December 2022 and May 2023, 70 participants (42 radiation oncologists, 12 medical oncologists, 14 head and neck surgeons, and 2 physicians covering several specialties) responded to our web-based survey. In addition to the type of institution (university hospital, private practice, etc.), their age, and professional experience (in years), participants were asked several questions on the indication and institutional policy for tube placement and management (prophylactic/reactive nasogastric or gastrostomy tube). All questions were mandatory single- or multiple-choice questions, while additional comments were possible by email. Most participants were employed at a university hospital (n = 52; 74.3%) and came from a radiation oncology background (n = 42; 60%). Fifty-four contributors (77.1%) reported that no nutritional risk screening prior to chemoradiotherapy was routinely performed, and 71.4% (n = 50) stated that no standardized protocol was used at the institution to set the indication for tube placement. Generally, policies and methods of tube feeding vary considerably between the individual institutions and specialties. However, the majority (n = 56, 80%) recommended a prophylactic percutaneous enteral gastrostomy (PEG) tube to their patients before chemoradiotherapy. Still, there was no consistent trend regarding the approach for reactive tube feeding. The policies and methods of tube feeding vary considerably between the individual institutions and specialties in Germany. In the era of individualized medicine, uniform protocols are difficult to establish. However, a baseline nutritional risk screening could simplify decision-making in clinical practice.
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
Data on enteral tube feeding in head and neck cancer (HNC) patients undergoing chemoradiotherapy vary considerably between German institutions. This survey aims to investigate the management of feeding tubes in an interdisciplinary context across Germany.
MATERIALS AND METHODS
METHODS
Between December 2022 and May 2023, 70 participants (42 radiation oncologists, 12 medical oncologists, 14 head and neck surgeons, and 2 physicians covering several specialties) responded to our web-based survey. In addition to the type of institution (university hospital, private practice, etc.), their age, and professional experience (in years), participants were asked several questions on the indication and institutional policy for tube placement and management (prophylactic/reactive nasogastric or gastrostomy tube). All questions were mandatory single- or multiple-choice questions, while additional comments were possible by email.
RESULTS
RESULTS
Most participants were employed at a university hospital (n = 52; 74.3%) and came from a radiation oncology background (n = 42; 60%). Fifty-four contributors (77.1%) reported that no nutritional risk screening prior to chemoradiotherapy was routinely performed, and 71.4% (n = 50) stated that no standardized protocol was used at the institution to set the indication for tube placement. Generally, policies and methods of tube feeding vary considerably between the individual institutions and specialties. However, the majority (n = 56, 80%) recommended a prophylactic percutaneous enteral gastrostomy (PEG) tube to their patients before chemoradiotherapy. Still, there was no consistent trend regarding the approach for reactive tube feeding.
CONCLUSION
CONCLUSIONS
The policies and methods of tube feeding vary considerably between the individual institutions and specialties in Germany. In the era of individualized medicine, uniform protocols are difficult to establish. However, a baseline nutritional risk screening could simplify decision-making in clinical practice.
Identifiants
pubmed: 38381142
doi: 10.1007/s00066-024-02206-w
pii: 10.1007/s00066-024-02206-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Unsal D, Mentes B, Akmansu M et al (2006) Evaluation of Nutritional Status in Cancer Patients Receiving Radiotherapy: A Prospective Study. American Journal of Clinical Oncology 29.
Jager-Wittenaar H, Dijkstra PU, Vissink A et al (2011) Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer. Head Neck 33:490–496
doi: 10.1002/hed.21473
pubmed: 20824806
Capuano G, Gentile PC, Bianciardi F et al (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18:433–437
doi: 10.1007/s00520-009-0681-8
pubmed: 19562384
Löser A, Avanesov M, Thieme A et al (2022) Nutritional Status Impacts Quality of Life in Head and Neck Cancer Patients Undergoing (Chemo)Radiotherapy: Results from the Prospective HEADNUT Trial. Nutr Cancer 74:2887–2895
doi: 10.1080/01635581.2022.2042571
pubmed: 35209777
Datema FR, Ferrier MB, Baatenburg de Jong RJ (2011) Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer. Oral Oncol 47:910–914
doi: 10.1016/j.oraloncology.2011.06.510
pubmed: 21802345
Cristofaro MG, Barca I, Ferragina F et al (2021) The health risks of dysphagia for patients with head and neck cancer: a multicentre prospective observational study. J Transl Med 19:472
doi: 10.1186/s12967-021-03144-2
pubmed: 34809654
pmcid: 8607588
Nutting C, Finneran L, Roe J et al (2023) Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol 24:868–880
doi: 10.1016/S1470-2045(23)00265-6
pubmed: 37423227
Barbon CEA, Peterson CB, Moreno AC et al (2022) Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia. JAMA Otolaryngol Head Neck Surg 148:956–964
doi: 10.1001/jamaoto.2022.2313
pubmed: 36074459
pmcid: 9459910
Kondrup J, Allison SP, Elia M et al (2003) ESPEN guidelines for nutrition screening 2002. Clin Nutr 22:415–421
doi: 10.1016/S0261-5614(03)00098-0
pubmed: 12880610
Dragan T, Duprez F, van Gossum A et al (2021) Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists. Bmc Cancer 21:656
doi: 10.1186/s12885-021-08348-9
pubmed: 34078309
pmcid: 8171041
McClelland S, Andrews JZ, Chaudhry H et al (2018) Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review. Oral Oncol 87:77–81
doi: 10.1016/j.oraloncology.2018.10.028
pubmed: 30527247
Dragan T, van Gossum A, Duprez F et al (2022) Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study. Trials 23:1036
doi: 10.1186/s13063-022-06991-6
pubmed: 36539781
pmcid: 9768988
Bossola M, Antocicco M, Pepe G (2022) Tube feeding in patients with head and neck cancer undergoing chemoradiotherapy: A systematic review. Jpen J Parenter Enteral Nutr 46:1258–1269
doi: 10.1002/jpen.2360
pubmed: 35244947
Grant DG, Bradley PT, Pothier DD et al (2009) Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol 34:103–112
doi: 10.1111/j.1749-4486.2009.01889.x
pubmed: 19413607
Chang W‑K, Huang H‑H, Lin H‑H et al (2019) Percutaneous Endoscopic Gastrostomy versus Nasogastric Tube Feeding: Oropharyngeal Dysphagia Increases Risk for Pneumonia Requiring Hospital Admission. Nutrients
Fan L, Li J, Xiang M et al (2018) Attitudes of radiation oncologists to percutaneous endoscopic gastrostomy in patients with head and neck cancer and eating difficulties: A survey in China. J Int Med Res 46:1709–1716
doi: 10.1177/0300060518756244
pubmed: 29512428
pmcid: 5991233
Ilmarinen T, Hammarstedt-Nordenvall L, Bäck L et al (2021) Enteral tube feeding of head and neck cancer patients undergoing definitive chemoradiotherapy in the Nordic Countries: Survey of the Scandinavian Society for Head and Neck Oncology. Eur Arch Otorhinolaryngol 278:3489–3496
doi: 10.1007/s00405-020-06545-z
pubmed: 33389006
Bozzetti F, Gurizzan C, Lal S et al (2022) A European survey on the practice of nutritional interventions in head-neck cancer patients undergoing curative treatment with radio(chemo)therapy. Eur Arch Otorhinolaryngol 279:1499–1508
doi: 10.1007/s00405-021-06920-4
pubmed: 34146151
Rainer Radtke SG) Anzahl der berufstätigen Ärzte in Deutschland nach Arztgruppe in den Jahren 2018 bis 2022. https://de.statista.com/statistik/daten/studie/158849/umfrage/aerzte-nach-taetigkeitsbereichen-in-deutschland/ . Accessed 11 Jun 2023.
Daniel Deininger) Facharzt-Weiterbildung Strahlentherapie: Dauer, Inhalte, Berufsperspektiven (2023. https://aerztestellen.aerzteblatt.de/de/redaktion/facharzt-weiterbildung-strahlentherapie . Accessed 11 Jun 2022.
Bundesärztekammer) Ärztestatistik zum 31. Dezember 2020. https://www.bundesaerztekammer.de/fileadmin/user_upload/_old-files/downloads/pdf-Ordner/Statistik_2020/2020-Statistik.pdf . Accessed 11 Jun 2023.
Eskander A, Irish J, Groome PA et al (2014) Volume-outcome relationships for head and neck cancer surgery in a universal health care system. Laryngoscope 124:2081–2088
doi: 10.1002/lary.24704
pubmed: 24706437
Torabi SJ, Benchetrit L, Yu KP et al (2019) Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 145:708–715
doi: 10.1001/jamaoto.2019.1187
pubmed: 31194229
pmcid: 6567848
David JM, Ho AS, Luu M et al (2017) Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer 123:3933–3942
doi: 10.1002/cncr.30843
pubmed: 28640546
Lehner U, Zaretsky E, Goeze A et al (2022) Nutritional Risk Screening in head-and-neck cancer patients prior to oncological therapy. Laryngorhinootologie 101:652–659
pubmed: 35500596
Liu W, Gao L, Huang X et al (2019) Pretreatment nutritional risk as a prognostic factor in head and neck cancer patients receiving radiotherapy or chemoradiotherapy. Asia Pac J Clin Nutr 28:223–229
pubmed: 31192550
Löser A, Abel J, Kutz LM et al (2021) Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial. Radiother Oncol 159:82–90
doi: 10.1016/j.radonc.2021.03.019
pubmed: 33766702
Yanni A, Dequanter D, Lechien JR et al (2019) Malnutrition in head and neck cancer patients: Impacts and indications of a prophylactic percutaneous endoscopic gastrostomy. Eur Ann Otorhinolaryngol Head Neck Dis 136:27–S33
doi: 10.1016/j.anorl.2019.01.001
Madhoun MF, Blankenship MM, Blankenship DM et al (2011) Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol 17:1004–1008
doi: 10.3748/wjg.v17.i8.1004
pubmed: 21448351
pmcid: 3057142
Baehr A, Hummel D, Gauer T et al (2023) Risk management patterns in radiation oncology-results of a national survey within the framework of the Patient Safety in German Radiation Oncology (PaSaGeRO) project. Strahlenther Onkol 199:350–359
doi: 10.1007/s00066-022-01984-5
pubmed: 35931889
Wright JL, Terezakis SA, Ford E (2021) Safety First: Developing and Deploying a System to Promote Safety and Quality in Your Clinic. Pract Radiat Oncol 11:92–100
doi: 10.1016/j.prro.2020.05.002
pubmed: 32450366
Yamazaki T, Enokida T, Wakasugi T et al (2016) Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiation. Jpn J Clin Oncol 46:825–831
doi: 10.1093/jjco/hyw079
pubmed: 27317736
Lewis SL, Brody R, Touger-Decker R et al (2014) Feeding tube use in patients with head and neck cancer. Head Neck 36:1789–1795
doi: 10.1002/hed.23538
pubmed: 24478227
Lang K, ElShafie RA, Akbaba S et al (2020) Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy. Cancer Manag Res 12:127–136
doi: 10.2147/CMAR.S218432
pubmed: 32021429
pmcid: 6955619
Machiels J‑P, René Leemans C, Golusinski W et al (2020) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up††These Guidelines were developed by the European Head and Neck Society (EHNS), the European Society for Medical Oncology (ESMO) and the European SocieTy for Radiotherapy & Oncology (ESTRO). The three societies nominated authors to write the guidelines as well as reviewers to comment on them. These guidelines were approved by the EHNS Executive Board, the ESMO Guidelines Committee and the ESTRO Executive Board in June 2020. Annals of Oncology 31:1462–75.
Finger A, Grohmann M, Krause L et al (2023) Irradiation dose to the swallowing apparatus impacts nutritional status in head and neck cancer patients-results from the prospective randomized HEADNUT trial. Strahlenther Onkol 199:875–880
doi: 10.1007/s00066-023-02124-3
pubmed: 37591979
pmcid: 10542726
Löser A, Grohmann M, Finger A et al (2022) Impact of dosimetric factors on long-term percutaneous enteral gastrostomy (PEG) tube dependence in head and neck cancer patients after (chemo)radiotherapy-results from a prospective randomized trial. Strahlenther Onkol 198:1016–1024
doi: 10.1007/s00066-022-01992-5
pubmed: 36006437
pmcid: 9581845
Villares MC, Tapia Risueño M, San Román Carbajo J et al (2003) Pretreatment dysphagia in patients with advanced head and neck cancer. Nutr Hosp 18:238–242